• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-21表面修饰的MB49细胞疫苗用于治疗小鼠转移性膀胱癌

[Interleukin-21 surface-modified MB49 cell vaccine for treatment of metastatic bladder in mice].

作者信息

Peng Junming, Shi Xiaojun, Chen Dingnan, Liang Zhongkun, Lan Kaijian, Gao Jimin, Tan Wanlong

机构信息

Department of Urinary Surgery, Southern Medical University, Guangzhou, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):807-11.

PMID:22699059
Abstract

OBJECTIVE

To develop a novel vaccine by immobilizing interleukin-21 (IL-21) on the surface of MB49 cells and evaluate its effect in inducing specific cytotoxic T lymphocytes (CTLs) and antitumor immunity in a mouse model of subcutaneous metastatic bladder cancer.

METHODS

SA-IL-21 was immobilized on the surface of 30% ethanol-fixed MB49 cells to prepare the cell vaccine. C57BL/6 mice with subcutaneous implantation of MB49 bladder cancer cells were randomized into 5 groups to receive treatments with IL-21/MB49 vaccine, soluble IL-21, GFP surface-modified MB49 cells, ethanol-fixed MB49 cells, or PBS. The tumor growth and CTL were examined to assess the antitumor efficacy of the vaccine.

RESULTS

IL-21 surface-modified MB49 cell vaccine significantly inhibited the tumor growth and generated a long-lasting memory response (P<0.05). At the same effector-target (E:T) ratio, the specific CTLs induced by IL-21/MB49 vaccine showed the most potent cytotoxicity against MB49 cells (P<0.05).

CONCLUSION

With the protein-anchor technique, IL-21 can be efficiently immobilized on the surface of MB49 cells to prepare IL-21/MB49 cells vaccine. The novel vaccine can maintain its biological activity and significantly enhance the cytotoxicity of CTLs against bladder cancer cells.

摘要

目的

通过将白细胞介素-21(IL-21)固定在MB49细胞表面来开发一种新型疫苗,并在皮下转移性膀胱癌小鼠模型中评估其诱导特异性细胞毒性T淋巴细胞(CTL)和抗肿瘤免疫的效果。

方法

将SA-IL-21固定在30%乙醇固定的MB49细胞表面以制备细胞疫苗。将皮下植入MB49膀胱癌细胞的C57BL/6小鼠随机分为5组,分别接受IL-21/MB49疫苗、可溶性IL-21、绿色荧光蛋白表面修饰的MB49细胞、乙醇固定的MB49细胞或PBS治疗。检测肿瘤生长和CTL以评估疫苗的抗肿瘤疗效。

结果

IL-21表面修饰的MB49细胞疫苗显著抑制肿瘤生长并产生持久的记忆反应(P<0.05)。在相同的效应细胞与靶细胞(E:T)比例下,IL-21/MB49疫苗诱导的特异性CTL对MB49细胞显示出最强的细胞毒性(P<0.05)。

结论

利用蛋白质锚定技术,可将IL-21有效固定在MB49细胞表面以制备IL-21/MB49细胞疫苗。该新型疫苗可保持其生物活性,并显著增强CTL对膀胱癌细胞的细胞毒性。

相似文献

1
[Interleukin-21 surface-modified MB49 cell vaccine for treatment of metastatic bladder in mice].白细胞介素-21表面修饰的MB49细胞疫苗用于治疗小鼠转移性膀胱癌
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):807-11.
2
Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.序贯给予 GM-CSF 和 IL-2 表面修饰的 MB49 细胞疫苗治疗转移性膀胱癌。
Urol Oncol. 2013 Aug;31(6):883-93. doi: 10.1016/j.urolonc.2011.08.001. Epub 2011 Sep 15.
3
Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.用表面修饰人白细胞介素-2 的 MB 49 细胞疫苗治疗转移性膀胱癌的新型免疫疗法。
Urology. 2011 Sep;78(3):722.e1-722.e6. doi: 10.1016/j.urology.2011.04.044. Epub 2011 Jul 13.
4
A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.一种新型治疗性疫苗,用鼠 GM-CSF 表面修饰 MB49 细胞,用于转移性膀胱癌。
J Urol. 2012 Mar;187(3):1071-9. doi: 10.1016/j.juro.2011.10.126. Epub 2012 Jan 21.
5
Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.利用白细胞介素-2表面修饰的MB49膀胱癌干细胞疫苗开发转移性膀胱癌治疗方法。
Stem Cell Res Ther. 2015 Nov 14;6:224. doi: 10.1186/s13287-015-0211-1.
6
[Intravesical anchoring of streptavidin-tagged interleukin-4 fusion protein for immunotherapy of mouse superficial bladder cancer].[链霉亲和素标记的白细胞介素-4融合蛋白膀胱内锚定用于小鼠浅表性膀胱癌的免疫治疗]
Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):331-5.
7
Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.通过联合给予粒细胞巨噬细胞集落刺激因子和白细胞介素-2表面修饰的MB49膀胱癌干细胞疫苗对转移性膀胱癌进行免疫治疗。
Cancer Med. 2017 Mar;6(3):689-697. doi: 10.1002/cam4.1023. Epub 2017 Feb 16.
8
A novel immunotherapy for superficial bladder cancer by the immobilization of streptavidin-tagged bioactive IL-2 on the biotinylated mucosal surface of the bladder wall.一种通过将链霉亲和素标记的生物活性白细胞介素-2固定在膀胱壁生物素化黏膜表面来治疗浅表性膀胱癌的新型免疫疗法。
Chin J Cancer. 2010 Jun;29(6):611-6. doi: 10.5732/cjc.009.10640.
9
The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer.粒细胞巨噬细胞集落刺激因子表面修饰的MB49膀胱癌干细胞疫苗用于治疗转移性膀胱癌。
Stem Cell Res. 2014 Jul;13(1):111-22. doi: 10.1016/j.scr.2014.04.006. Epub 2014 Apr 24.
10
[Immobilization of streptavidin-tagged bioactive hTNF-alpha on biotinylated mucosal surface of the bladder wall for treatment of superficial bladder cancer in mice].[将链霉亲和素标记的生物活性人肿瘤坏死因子-α固定于膀胱壁生物素化黏膜表面用于治疗小鼠浅表性膀胱癌]
Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):936-40.

引用本文的文献

1
The past, present, and future of immunotherapy for bladder tumors.膀胱癌免疫治疗的过去、现在和未来。
Med Oncol. 2022 Sep 29;39(12):236. doi: 10.1007/s12032-022-01828-3.